Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goserelin for Prevention of Chemotherapy-Induced Ovarian Failure in Lymphoma
NCT04536467Phase 2Enrolling by invitation
- Sponsor
- Beni Suef University
- Start
- Mar 2019
- Primary completion
- Dec 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of goserelin in primary ovarian insufficiency (POI), sponsored by Beni Suef University. Started Mar 2019; status: enrolling by invitation.
02
Drugs
goserelin
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT04536467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536467.